Conference Coverage

Salk: Low-Dose Immunization May Be Key to HIV Vaccine

Published in Vaccine Weekly, April 3rd, 1995

Low-dose vaccination coupled with antiretroviral therapy might prevent progression to AIDS in people with HIV infection, according to polio vaccine inventor Jonas Salk.

In his keynote lecture to the Third Annual Vaccines: New Technologies and Applications Conference, held March 20-22 in Alexandria, Virginia, Salk recommended testing a strategy for AIDS therapy that would take advantage of the potential synergy between immune-based and antiretroviral treatments. He suggested that immunization designed to elicit functional cell-mediated memory could be combined with antiretroviral agents to decrease viral burden.

"The two together could result in the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1995-04-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry